Equity Profile
Pre-Earnings Brief
Hercules Capital, Inc. (HTGC) is a financial services company that specializes in providing debt and equity financing to venture capital-backed companies....
EPS
Earnings per share is a critical measure of profitability and will indicate how well the company is managing its investments.
Revenue
Total revenue reflects the company's ability to generate income from its financing activities, which is crucial for assessing growth.
Wall Street expectations, options signals, track record, and call prep available with Pro.
EPS Beat Streak
0Q
EPS Beat Rate
38%
Avg EPS Surprise
-7.26%
Avg Stock Reaction
-0.55%
In the last quarter, Hercules Capital reported earnings that matched analyst expectations, with an EPS of $0.48. However, the stock experienced a slight decline the following day, reflecting investor caution.
Management Promises & Guidance
Analysts expect Hercules Capital to report earnings in line with consensus estimates, with a focus on maintaining profitability amid market volatility. Investors will be watching closely for any signs of growth or challenges in their portfolio companies.
Bull Case
If Hercules Capital exceeds EPS expectations and shows strong revenue growth, it could signal robust demand for its financing services, leading to increased investor confidence.
Bear Case
Conversely, if the company misses earnings expectations or provides weak guidance, it could raise concerns about its portfolio's health and lead to a sell-off in the stock.
EPS
0.47Earnings per share is a critical measure of profitability and will indicate how well the company is managing its investments.
Revenue
141MTotal revenue reflects the company's ability to generate income from its financing activities, which is crucial for assessing growth.
Expectations
The print will turn on these two things.
Q1
Will Hercules Capital achieve an EPS of at least $0.47?
This number is crucial as it sets the benchmark for investor expectations and reflects the company's profitability.
Q2
What is the outlook for revenue growth in the upcoming quarters?
Understanding revenue trends will help gauge the company's ability to sustain its financing activities and support its portfolio companies.
Edge
Why consensus could be wrong
The Street may be underestimating the potential for Hercules Capital to outperform due to its strong relationships with high-growth companies, which could lead to better-than-expected revenue.
Supporting Evidence
The options market is pricing a significant move, indicating that investors anticipate volatility, which could be due to positive sentiment.
Historical performance shows that Hercules has a 50% EPS beat rate, suggesting potential for upside surprises.
Key Risk
If the company reports strong portfolio performance and revenue growth, it could challenge the current cautious outlook.
Edge
Pre-commit to what would confirm each case.
The market is debating whether Hercules Capital can maintain its profitability and growth trajectory in a challenging economic environment.
Bull Confirmed If
An EPS of $0.49 or higher with revenue exceeding $145M would confirm strong operational performance.
Bear Confirmed If
An EPS below $0.44 or revenue below $138M would raise concerns about the company's financial health.
Pre-Earnings Positioning
Implied Move
±7.51%
Historical Avg
±0.7%
The options market is pricing in a significant move following the earnings report, indicating that investors expect volatility.
Options are pricing ±5.7% while HTGC has averaged ±0.7% over the last 8 prints — setup is pricing rich.
ATM IV
0.4%
30d HV
28.6%
Preparation
Likely market behavior by outcome — not investment advice.
Beat & Raise
If Hercules Capital beats expectations, history suggests the stock could see a modest increase, confirming a positive outlook for growth.
In-Line / Cautious
If results are in line with expectations, the stock may experience limited movement, reflecting cautious sentiment from investors.
Miss
Should the company miss earnings expectations, history suggests a potential decline in stock price, as seen in previous quarters.
Preparation
House & Senate STOCK Act disclosures over the trailing 6 months.
Trades
2
1 buy·1 sell
Members
1
House only
Est. Notional
$51,002.00–$115,000.00
disclosed dollar ranges
Most Active Members
2 trades
Mixed
Recent Transactions
Traded Jan 12, 2026 · disclosed Feb 6, 2026
$50,001.00–$100,000.00
Traded Nov 19, 2025 · disclosed Dec 1, 2025
$1,001.00–$15,000.00
Filed 30–45+ days after the trade. Treat as positional context, not a leading indicator. Amounts are SEC-mandated dollar ranges, not exact values.
Preparation
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
Axsome Therapeutics, Inc.